Literature DB >> 15857936

Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.

Waithaka Mwangi1, Wendy C Brown, Gary A Splitter, Yan Zhuang, Kimberly Kegerreis, Guy H Palmer.   

Abstract

Induction of immune responses against microbial antigens using DNA is an attractive strategy to mimic the immunity induced by live vaccines. Although DNA vaccines are efficacious in murine models, the requirement for multiple immunizations using high doses in outbred animals and humans has hindered deployment. This requirement is, in part, a result of poor vaccine spreading and suboptimal DC transfection efficiency. Incorporation of a signal that directs intercellular spreading of a DNA-encoded antigen is proposed to mimic live vaccine spreading and increase dendritic cell (DC) presentation. Bovine herpes virus 1 tegument protein, BVP22, is capable of trafficking to surrounding cells. To test the hypothesis that BVP22 enhances spreading and antigen presentation to CD4+ T cells, a DNA construct containing BVP22, fused in-frame to a sequence encoding a T cell epitope of Anaplasma marginale, was generated. A construct with reversed BVP22 sequence served as a negative control. Immunocytometric analysis of transfected primary keratinocytes, human embryonic kidney 293, COS-7, and Chinese hamster ovary cells showed that BVP22 enhanced intercellular spreading by > or = 150-fold. Flow cytometric analysis of antigen-presenting cells (APCs) positively selected from cocultures of transfected cells and APCs showed that 5% of test APCs were antigen-positive, compared with 0.6% of control APCs. Antigen-specific CD4+ T cell proliferation demonstrated that BVP22 enhanced DC antigen presentation by > or = 20-fold. This first report of the ability of BVP22 to increase DNA-encoded antigen acquisition by DCs and macrophages, with subsequent enhancement of major histocompatibility complex class II-restricted CD4+ T cell responses, supports incorporating a spreading motif in a DNA vaccine to target CD4+ T cell-dependent immunity in outbred animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857936     DOI: 10.1189/jlb.1204722

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen.

Authors:  Yan Zhuang; Waithaka Mwangi; Wendy C Brown; William C Davis; Jayne C Hope; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2006-09

Review 4.  Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

Authors:  Shaw-Wei D Tsen; Augustine H Paik; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

Review 5.  DNA vaccines for cervical cancer: from bench to bedside.

Authors:  Chien-Fu Hung; Archana Monie; Ronald D Alvarez; T-C Wu
Journal:  Exp Mol Med       Date:  2007-12-31       Impact factor: 8.718

Review 6.  Therapeutic HPV DNA vaccines.

Authors:  Archana Monie; Shaw-Wei D Tsen; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

7.  The effect of bovine viral diarrhea virus (BVDV) strains on bovine monocyte-derived dendritic cells (Mo-DC) phenotype and capacity to produce BVDV.

Authors:  Mrigendra K S Rajput; Mahmoud F Darweesh; Kaci Park; Lyle J Braun; Waithaka Mwangi; Alan J Young; Christopher C L Chase
Journal:  Virol J       Date:  2014-03-07       Impact factor: 4.099

8.  Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.

Authors:  Cameron Martin; Suryakant D Waghela; Shehnaz Lokhandwala; Andy Ambrus; Jocelyn Bray; Christina Vuong; Vanitha Vinodkumar; Paul J Dominowski; Sharath Rai; Duncan Mwangi; Dennis L Foss; Waithaka Mwangi
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

9.  The Effect of Bovine Viral Diarrhea Virus (BVDV) Strains and the Corresponding Infected-Macrophages' Supernatant on Macrophage Inflammatory Function and Lymphocyte Apoptosis.

Authors:  Karim Abdelsalam; Mrigendra Rajput; Gamal Elmowalid; Jacob Sobraske; Neelu Thakur; Hossam Abdallah; Ahmed A H Ali; Christopher C L Chase
Journal:  Viruses       Date:  2020-06-29       Impact factor: 5.048

10.  An intradermal inoculation model of scrub typhus in Swiss CD-1 mice demonstrates more rapid dissemination of virulent strains of Orientia tsutsugamushi.

Authors:  Piyanate Sunyakumthorn; Daniel H Paris; Teik-Chye Chan; Margaret Jones; Alison Luce-Fedrow; Suchismita Chattopadhyay; Ju Jiang; Tippawan Anantatat; Gareth D H Turner; Nicholas P J Day; Allen L Richards
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.